Now that it is possible to create pluripotent stem cells without the need for embryos, stem cell research labs are springing up by the hundreds – despite the fact that one critical problem still remains.
The politics of stem cells are reviewed within the context of the current U.S. presidential election.
The stem cell company Neuralstem, Inc., announces the licensing of patents for the delivery of targeted spinal cord therapeutics.
European researchers have coaxed testicular sperm-producing cells into new cells that behave like embryonic stem cells.
Lured by the promise of financial profit, the pharmaceutical giant Pfizer joins the stem cell community.
At the start of a major conference, the man who first introduced embryonic stem cells to the world delivers a cautionary message.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.
